http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IL-122261-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7797fadff68d537c70da7bfdd36b61c6 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0026 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-06 |
| filingDate | 1996-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2001-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | IL-122261-A |
| titleOfInvention | Fluorocarbons Liquids for the treatment of conditions caused by a deficiency in the endogenous level of nitric oxide |
| abstract | Use of a liquid fluorocarbon emulstion for the manufacture of a pharmaceutical composition in a form suitable for intravenous administration substantially as described in the specification for increasing the amount and the stable half-life of nitric oxide circulating in the bloodstream of a patient in need of an increase in the amount and stable half-life of circulating nitric oxide, substantially as described in the specification. |
| priorityDate | 1995-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.